Nuvectis Pharma
NVCT
NVCT
33 hedge funds and large institutions have $16.5M invested in Nuvectis Pharma in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 14 increasing their positions, 13 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
Holders
33
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$579K | |
| 2 | +$339K | |
| 3 | +$325K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$221K |
| 5 |
MWM
Moran Wealth Management
Naples,
Florida
|
+$215K |
Top Sellers
| 1 | -$448K | |
| 2 | -$425K | |
| 3 | -$364K | |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$200K |
| 5 |
Renaissance Technologies
New York
|
-$142K |